powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1881246858
Catherine Flynn
PRACTICE
DANA-FARBER CANCER INSTITUTE, INC.
See all providers at this practice →
Nurse Practitioner
Boston,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$124
Payment records
1
By payment type
Food and Beverage
$124
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
724
Beneficiaries
—
Total drug cost
$9.6M
Distinct drugs
8
Brand share
93.6%
Top prescribed drugs
Zanubrutinib
382 claims
Ibrutinib
153 claims
Venetoclax
65 claims
Lenalidomide
55 claims
Lenalidomide
17 claims